Senate CR delays OMB review of agency rules.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Senate CR delays OMB review of agency rules.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Office of Management and Budget
agency that prepares and evaluates the President of the United States' annual budget to Congress
Related events
- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.
- The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- Humane World for Animals petitioned the FDA and lobbied Congress regarding drug approval regulations.
- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.